The methylation cycle, explained — from DNA to neurotransmitters

Most articles about methylation start with MTHFR and stop there. That’s a shame, because MTHFR is one gene in a cycle of at least a dozen, and the cycle itself is far more interesting than any single variant.

Methylation is how your body turns raw B-vitamins into the chemistry of thought, mood, detoxification, and gene expression. It runs in every cell, every second of your life. When it works, you never notice it. When it doesn’t, you notice everything — fatigue, brain fog, low mood, poor sleep, slow recovery.

Here’s what the cycle actually does, why it matters, and where the leverage points sit.

What “methylation” actually means

At the chemistry level, methylation is the transfer of a methyl group — one carbon and three hydrogens, CH₃ — from a donor molecule to an acceptor molecule. That tiny hand-off is the fundamental unit of work in one-carbon metabolism, the biochemical network that sits underneath gene expression, neurotransmitter synthesis, and detoxification [1].

Each methyl transfer is small. But your body performs billions of them every second. Methyl groups:

• Turn genes on and off (DNA methylation)
• Build dopamine, serotonin, norepinephrine, and melatonin
• Produce phosphatidylcholine for cell membranes
• Clear homocysteine from the blood
• Synthesize creatine, carnitine, and CoQ10
• Support glutathione production for detoxification

One missing cofactor at the wrong step and the whole system slows.

The cycle, in five movements

The methylation cycle is actually two interlocking loops — the folate cycle and the methionine cycle — that trade methyl groups between each other. Here’s the short version:

1. Folate enters the cycle

Dietary folate (from leafy greens, legumes, liver) or synthetic folic acid (from fortified grains) enters the folate cycle. To become biochemically useful, it must be converted — through several enzymatic steps — into L-5-methyltetrahydrofolate (5-MTHF), the only folate form your cells can use directly.

The final and rate-limiting step is catalyzed by the MTHFR enzyme. If you carry a C677T or A1298C variant, this step runs at 30–70% of normal capacity.

2. Folate hands its methyl group to B12

5-MTHF passes its methyl group to vitamin B12 (cobalamin), producing methylcobalamin. The enzyme that facilitates this hand-off is methionine synthase (MTR), with a helper enzyme — methionine synthase reductase (MTRR) — keeping the B12 cofactor in its active state. Variants in MTRR (A66G) are associated with modest elevations in homocysteine, independent of folate and B12 intake [2].

3. Methyl-B12 re-methylates homocysteine to methionine

Now the cycle crosses into the methionine loop. Methyl-B12 donates its methyl group to homocysteine, converting it into methionine. This step is the body’s primary method of clearing homocysteine — a toxic sulfur-containing amino acid that, when elevated, is linked with cardiovascular risk and cognitive decline [3].

4. Methionine becomes SAM-e — the universal methyl donor

Methionine immediately picks up a high-energy phosphate and becomes S-adenosylmethionine (SAM-e), the universal methyl donor. SAM-e is the molecule that actually performs methyl transfers all over the body — methylating DNA, histones, neurotransmitter precursors, phospholipids, and dozens of other substrates [4].

When SAM-e donates its methyl group, it becomes S-adenosylhomocysteine (SAH), which is hydrolyzed back to homocysteine — and the cycle starts over.

5. An alternate route: betaine and BHMT

There’s a parallel pathway worth knowing about. Betaine (from choline or dietary sources like beets and spinach) can re-methylate homocysteine via the BHMT enzyme — a folate- and B12-independent backup. For people with severely impaired folate metabolism, this route matters.

Q: If methylation is this big a system, why does everyone only talk about MTHFR?

A: Because MTHFR has the most-studied polymorphisms and the clearest enzyme-activity reduction. But it’s one gene in a network. Practitioners who only treat MTHFR often miss patients whose bottleneck is actually at MTR, MTRR, BHMT, or COMT downstream. A full picture — from a test like GenePro+ — shows the whole cycle, not just the most famous enzyme.

What methylation produces (and why you care)

The output of the methylation cycle isn’t abstract. It’s the chemistry of feeling like yourself:

• Mood: Serotonin, dopamine, and norepinephrine are synthesized from amino acid precursors via methylation-dependent enzymes. Folate-deficient patients show significantly reduced monoamine metabolites in cerebrospinal fluid [5]. This is part of why folate status and depression are tightly linked — and why L-methylfolate has been studied as augmentation for SSRI-resistant depression [6].
• Energy: Methylation builds CoQ10 and carnitine, two molecules your mitochondria need to make ATP. When methylation is underpowered, cellular energy output follows.
• Gene expression: DNA methylation switches genes on and off in response to the environment. The nutrients that feed the cycle — folate, B12, choline, methionine — are literally the substrate of epigenetics [1].
• Detoxification: Glutathione synthesis depends on homocysteine moving down the trans-sulfuration branch of the cycle. Without adequate cycle flux, glutathione production drops.
• Cardiovascular support: Elevated homocysteine — a direct readout of stalled methylation — is associated with vascular stiffening and cognitive decline.

Where the cycle breaks

Five common points of failure, in rough order of prevalence:

1. MTHFR variants reduce the activation of folate into 5-MTHF.
2. Low B12 (dietary, absorption-related, or from PPI/metformin use) stalls homocysteine re-methylation. Holotranscobalamin and methylmalonic acid catch this earlier than serum B12 alone [7].
3. Low riboflavin (B2) — the cofactor MTHFR itself requires — limits enzyme function. In hypertensive patients with MTHFR 677TT, a daily 1.6 mg riboflavin dose meaningfully lowered blood pressure in a randomized trial [8].
4. Depleted SAM-e or upstream methionine starves downstream methyltransferases.
5. Fast COMT or other downstream variants change how methyl groups are consumed — especially in the brain, where COMT helps clear dopamine and norepinephrine from synapses [9].

For deeper reading on how these breaks show up as symptoms, see our companion piece on how methylation shapes mood, focus, and energy.

What “supporting” the cycle actually looks like

There’s no universal methylation stack. But the inputs the cycle runs on are consistent:

• Bioactive folate as L-5-MTHF and/or folinic acid (bypasses the MTHFR bottleneck)
• Active B12 as methylcobalamin or hydroxocobalamin (feeds the MTR hand-off)
• B6 as P5P (supports trans-sulfuration of homocysteine to glutathione)
• Riboflavin (B2) as FAD cofactor for MTHFR itself
• Choline, betaine, or TMG for the BHMT alternate pathway
• Magnesium, zinc as cofactors for dozens of methyltransferases

Methylation Complete™ is designed around this logic: a sublingual B12/B6/folate trio that delivers every bioactive B in one tablet. For patients who need a higher clinical dose of folate specifically, Methyl Folate Plus™ stacks L-5-MTHF with folinic acid plus B2 and B3 cofactors.

The short version

• Methylation is the transfer of methyl groups from donor to acceptor molecules — it powers neurotransmitter synthesis, DNA methylation, detoxification, and energy metabolism.
• The cycle is two loops (folate + methionine) that trade methyl groups through MTHFR, MTR, MTRR, BHMT, and SAM-e-dependent methyltransferases.
• Single-gene focus (just MTHFR) misses the system. A full methylation-pathway view — including B12 status markers and downstream enzymes like COMT — is what clinical reality usually looks like.
• Supporting the cycle means feeding it the active cofactors it already uses — not forcing high-dose single nutrients.

If you’re new to the topic and want to start with the gene most people hear about first, read what is MTHFR. If you’re ready to look at the full pathway as a testable system, GenePro+ maps 100+ markers across 11 wellness categories — including the full methylation cycle.

---

This article is educational and does not constitute medical advice. Methylation support protocols should be individualized and reviewed with a qualified healthcare provider, especially during pregnancy or if you take prescription medications.

References

1. Mentch SJ, Locasale JW. One-carbon metabolism and epigenetics: understanding the specificity. Ann N Y Acad Sci. 2016;1363:91–98. PMID: 26647078
2. Gaughan DJ, Kluijtmans LAJ, Barbaux S, et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis. 2001;157(2):451–456. PMID: 11472746
3. Bottiglieri T, Laundy M, Crellin R, et al. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry. 2000;69(2):228–232. PMID: 10896698
4. Lee BWL, Ghode P, Ong DST. S-Adenosylmethionine: more than just a methyl donor. Nat Prod Rep. 2023;40(9):1521–1549. PMID: 36891755
5. Miller AL. The methylation, neurotransmitter, and antioxidant connections between folate and depression. Altern Med Rev. 2008;13(3):216–226. PMID: 18950248
6. Papakostas GI, Shelton RC, Zajecka JM, et al. L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry. 2012;169(12):1267–1274. PMID: 23212058
7. Jarquin Campos A, Risch L, Nydegger U, et al. Diagnostic Accuracy of Holotranscobalamin, Vitamin B12, Methylmalonic Acid, and Homocysteine in Detecting B12 Deficiency in a Large, Mixed Patient Population. Dis Markers. 2020;2020:7468506. PMID: 32089757
8. Wilson CP, Ward M, McNulty H, et al. Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial. Hypertension. 2013;61(6):1302–1308. PMID: 23608654
9. Schacht JP. COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review. Pharmacogenomics J. 2016;16(5):430–438. PMID: 27241058